SP 500 Edges Higher as Tech Surge Offsets Energy and Defensive Weakness Single Premium Immediate Annuity Offering 91 Payout Attracts Retirees Seeking Income Stability Ajmera Realty Shares Surge 96 on Strong FY26 Financial Results Overlooked Dividend King Industrial Sectors Hidden Gem May Offer LongTerm Value Alabamas April Unemployment Edges Higher as Manufacturing Wages Hit Record High 110th Indianapolis 500 Viewing Guide and Potential Economic Impact TAK Q1 2026 Earnings NarrowerthanExpected Loss as EPS Surprises Positively MRK Q1 2026 Earnings EPS Surprise on a Loss Stock Declines 22 BRKR Q1 2026 Earnings EPS Surges Past Estimates by Over 30 ACGLO Q1 2026 Earnings EPS Misses Estimates Amid Mixed Underwriting Conditions Sweetgreen Q1 2026 Earnings EPS Misses Estimates Yet Stock Gains on Operational Momentum SNES Q1 2026 Earnings NarrowerThanExpected Loss Drives Modest Stock Gain WhiteHorse Finance WHF Stock Slips Amid Narrow Trading Range Key Support and Resistance Levels in Focus LaFayette Acquisition Corp Unit LAFAU Holds Steady at 1006 Stability in a SPAC Market Bullish Ordinary Shares BLSH Holds Steady Near 3462 Amid Low Volume Trading Renatus Tactical Acquisition Corp I RTAC Holds Steady Near Resistance Key Levels in Focus MBX Biosciences MBX Surges Over 3 as Stock Approaches Key Resistance Level Russia Warns of Systematic Kyiv Strikes Escalating Geopolitical Risk for Global Markets Codere Online Q4 2025 Earnings Narrow Loss Surprises on the Downside Stock Edges Up Coincheck Group CNCK Slides 276 as CryptoRelated Volatility Persists Kodiak AI Inc KDK Q1 2026 Earnings Surprise Profit Beats Expectations Amid Revenue Disclosures XOMA Q1 2026 Earnings EPS Misses Estimates as Royalty Revenue Falls Short Edgewell Personal Care Company EPC Q1 2026 Earnings EPS Misses Estimates Amidst Operational Challenges Stock Edges Higher MWA Q1 2026 Earnings EPS Beats Estimates by 647 FULTP Q1 2026 Earnings Preferred Stock Delivers EPS Beat Despite Market Headwinds Verrica Pharmaceuticals VRCA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Sees Modest Stock Gain URGN Q1 2026 Earnings Narrower Loss Surprises as Revenue Details Remain Undisclosed